Based in the United States, Xilio Therapeutics is a startup. Brouky records 1 investor associated with the company.
Xilio Therapeutics is a clinical-stage biotechnology company focused on developing next-generation immuno-oncology therapies to improve cancer treatment outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.